MAPT and Alzheimer disease: Moran et al. suggested in a study including the ADNI cohort that TDM2 promotes and contributes to neurodegeneration independently of the diagnosis of AD via phosphorylation of the tau protein, supported by the lack of amyloid PET differences, but with the presence of differences in CSF tau between the diabetes/no diabetes groups [26].